Astellas Announces Presentation of Additional Positive XTANDI Data at ESMO 2016 (MDVN)
Go back to Astellas Announces Presentation of Additional Positive XTANDI Data at ESMO 2016 (MDVN)| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 9.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.49 | 52 Week High | $19.40 | |||
| Open | $9.49 | 52 Week Low | $12.50 | |||
| Day High | $9.49 | P/E | N/A | |||
| Day Low | $9.49 | EPS | $0.00 | |||
| Volume | 500 | |||||
| Medivation, Inc. (NASDAQ: MDVN) | Delayed: 81.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.44 | 52 Week High | $81.48 | |||
| Open | $3852.47 | 52 Week Low | $26.41 | |||
| Day High | $81.44 | P/E | N/A | |||
| Day Low | $81.44 | EPS | $-1.03 | |||
| Volume | 13,593 | |||||
